Douglas Friedman is CEO of BioMADE, the Bioindustrial Manufacturing Innovation Institute. His primary scientific and technical interests lie in the fields of synthetic biology, industrial biomanufacturing, and modern biotechnology. Doug's policy interests include the development of sustainable biotechnology, safeguarding the bioeconomy, and accelerating technical advancement by building diverse, robust community partnerships. He regularly serves as a subject matter expert on emerging biotechnologies, biotechnology policy, and national security topics at the interface of the biological and chemical sciences. Prior to BioMADE, Doug was the inaugural Executive Director of Engineering Biology Research Consortium (EBRC) and currently serves on its Steering Committee.  Prior to EBRC, he was a study director and senior program officer with the Board on Chemical Sciences and Technology at the National Academies of Sciences, Engineering, and Medicine where his focus was at the interface of chemistry and biology with a frequent focus on national security matters. Earlier in his career, Doug performed research in physical organic chemistry and chemical biology in academia and industry. He earned a Ph.D. in Chemistry from Northwestern University and a B.S. in Chemical Biology from the University of California, Berkeley.